May 16, 2016
Nathaniel Reichek, MD
Regardless of CV risk factors, angiography results or initial patient treatment, CV magnetic resonance is a stronger predictor of major adverse CV events than single-photon emission CT, according to new data from the CE-MARC study.
Between March 2006 and August 2009, the researchers randomly assigned 752 patients with suspected stable angina to CV magnetic resonance (CMR) followed by SPECT or SPECT followed by CMR. The primary outcome was major adverse CV events. Follow-up lasted approximately 5 years. The final-analysis population included 628 patients.
Meeting News Coverage
May 10, 2016
SAN FRANCISCO — Ventricular fibrillation mapping can accurately identify individual drivers, according to data presented at the Heart Rhythm Society Annual…
May 9, 2016
Biotronik announced that the FDA approved its MRI-conditional cardiac resynchronization therapy defibrillator for patients with HF.The device (Iperia ProMRI HF-T), which…
Meeting News CoverageVideo
May 7, 2016
CHICAGO — Jennifer Ann Tremmel, MD, an interventional cardiologist at Stanford University Medical Center, discusses alternative diagnoses in ACS in patients…